Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
Holding NRIX?
Track your performance easily

Nurix Therapeutics (NRIX) Financial Statements

401 Followers

Nurix Therapeutics Financial Overview

Nurix Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.91; its P/E ratio is -8.74; Nurix Therapeutics is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24May 24Feb 24Nov 23Aug 23
Income Statement-
Total Revenue$ 12.59M$ 12.09M$ 16.59M$ 15.16M$ 18.47M
Gross Profit$ 12.59M$ 12.09M$ 16.59M$ 15.16M$ 18.47M
EBIT$ -48.87M$ -44.46M$ -45.22M$ -41.96M$ -36.98M
EBITDA$ -44.73M$ -38.44M$ -41.33M$ -40.20M$ -35.24M
Net Income Common Stockholders$ -48.96M$ -44.55M$ -41.52M$ -41.96M$ -36.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 448.05M$ 443.14M$ 49.81M$ 54.63M$ 258.85M
Total Assets$ 513.60M$ 511.03M$ 312.67M$ 355.60M$ 308.19M
Total Debt$ 27.14M$ 28.82M$ 29.16M$ 30.61M$ 8.00M
Net Debt$ -420.91M$ -414.32M$ -20.66M$ -24.01M$ -250.85M
Total Liabilities$ 136.74M$ 140.34M$ 143.93M$ 155.10M$ 74.38M
Stockholders Equity$ 376.86M$ 370.66M$ 168.75M$ 200.49M$ 233.86M
Cash Flow-
Free Cash Flow$ -44.52M$ -41.64M$ -44.84M$ 24.10M$ -43.59M
Operating Cash Flow$ -42.18M$ -39.70M$ -41.95M$ 26.69M$ -41.13M
Investing Cash Flow$ -21.34M$ -131.07M$ 35.51M$ -14.37M$ 22.77M
Financing Cash Flow$ 45.77M$ 237.75M$ 1.62M$ 7.00K$ 1.70M
Currency in USD

Nurix Therapeutics Earnings and Revenue History

Nurix Therapeutics Debt to Assets

Nurix Therapeutics Cash Flow

Nurix Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis